OncoZenge

Bromma, Sweden

OncoZenge develops better products for the supportive care of cancer patients.

$1.6M raised

Jun 2026

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has OncoZenge raised?

OncoZenge has raised $1.6M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.

Who are OncoZenge's investors?

OncoZenge's investors include Sichuan Yangtian Bio-Pharmaceutical, Linc, Ostersjöstiftelsen.

Where is OncoZenge headquartered?

OncoZenge is headquartered in Bromma, Sweden.

What does OncoZenge do?

OncoZenge develops better products for the supportive care of cancer patients.

What stage is OncoZenge at?

OncoZenge is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 5, 2026.

MLA

"OncoZenge — Funding & Investors." VCBacked, June 5, 2026, https://www.vcbacked.co/company/oncozenge. Accessed July 3, 2026.

APA

VCBacked. (2026). OncoZenge — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/oncozenge

Wikipedia (cite web)

{{cite web |title=OncoZenge — Funding & Investors |url=https://www.vcbacked.co/company/oncozenge |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 5, 2026.